Do you want to stay up to date on the Anticancer Fund?
Sign up and we will send you news about our trials, our insights on cancer research and about our service for cancer patients My Cancer Navigator. We promise we will not overwhelm you!
*
geeft verplicht aan
Name:
Email:
Comment:
First Name
*
Last Name
*
Email Address
*
Language
*
English
Dutch
French
Gelieve een of meer mogelijkheden te kiezen:
Ja, ik wil alles weten van het Antikankerfonds
Ik ben journalist, stuur mij enkel persberichten.
Ik wil graag de wetenschappelijke updates over Drug Repurposing in Oncology ontvangen
Please choose one of these options:
Yes, I want to know everything about the Anticancer Fund
I'm a journalist, please send me your press releases
I would like to subscribe to the Scientific updates about Drug Repurposing in Oncology
Press
Press - national
Press - regional
Press - international
Testament.be
Testament NL 2023-2024
Testament FR 2023-2024
Fundraising
Recurrent donateurs
Occasional donateurs
Private Banking
Testators/erflater kandidaten
Patient Representatives
Individual
Patient organizations
Researchers / Health Care Professionals
Support organizations
GPs
Researchers/Health Care Professionals
Backoffice ACF
Team
Board
students, ex-team,..
Friends & family
Advisory Board
suppliers & consultants
Service providers
Pharma
suppport organizations & federations
Companies
Roundtable Pharma
Policy
EU Parliament
EU Commission
Public Health & Politicians
Regulators
Others
Sympathisers
Undefined
MCN
Peers
Peers
RFA
General RFA
ET Specific
RFA PDAC/BTC
RFA BM
COVID19_DB
COVID19_DB
Cell therapy
Cell therapy
Webinar 16/10/2023
Webinar 16/10/2023
Veuillez choisir l'une des options suivantes :
Oui, je veux tout savoir du Fonds Anticancer
Je suis journaliste, veuillez m'envoyer vos communiqués de presse
Je souhaite m'abonner aux 'Scientific updates about Drug Repurposing in Oncology'
Kies een van deze opties:
Ja, ik wil alles weten over het Antikankerfonds
Ik ben journalist, stuur mij de persberichten
Ik wil me abonneren op 'Scientific updates about Drug Repurposing in Oncology'
Press release De Tijd 08102024
De Tijd 08102024